8:00 AM: ARRIVAL

Registration, Breakfast, Networking

8:45 AM: WELCOMING REMARKS

8:55 AM: STATE OF THE ECOSYSTEM

9:15 AM: STRENGTHENING THE UNIVERSITY-CORPORATE CONNECTION – BIOTECH AND BEYOND: A Conversation with University Presidents

MODERATOR:
Brian K. Fitzgerald, EdD, CEO, Business-Higher Education Forum

SPEAKERS:
Ángel Cabrera, President, George Mason University
Dr. Wallace D. Loh, President, University of Maryland, College Park
Jay A. Perman, MD, President, University of Maryland, Baltimore

10:15 AM: UNIVERSITIES: FROM RESEARCH TO COMMERCIALIZATION

11:00 AM: NETWORKING BREAK

12:30 PM: LUNCH

1:30 PM: ANGEL INVESTORS: WHERE ARE THEY? WHAT DO THEY WANT? HOW DO I ACCESS THEM?

INTRODUCTION BY:
John Trainer, Vice President & Head, Partnering & Strategy, MedImmune

MODERATOR:
Jonathan Aberman, Managing Director, Amplifier Ventures

PANELISTS:
Jeff Galvin, CEO & Founder, American Gene Technologies International Inc.
Merom Klein, Principal, Courage Growth Partners
Paul Silber, PhD, Founding Principal, Blu Venture Investors
Dendy Young, Managing Partner, McLean Capital LLC

2:30 PM: INVESTORS WITH A LOCAL PRESENCE

MODERATOR:
Andy Jones, Chief Investment Officer, TEDCO

PANELISTS:
Mike Thomas, Director, Inova Personalized Health Accelerator (IPHA)
Chris Otey, Senior Vice President, Science and Technology, Alexandria Real Estate Equities, Inc.
Cherine Eldumiati Plumaker, Managing Director, Pansend Life Sciences, LLC
David A. Present, MD, President & Senior Managing Director, Panned Life Sciences, LLC
R. Jacob Vogelstein, Partner & Portfolio Manager, Camden Partners Holdings, LLC

3:30 PM: NETWORKING BREAK

4:00 PM: Measurements, Standards, and Innovation for Better Health Care

INTRODUCTION:
Gail Wasserman, PhD, Senior Vice President, Biopharmaceutical Development, MedImmune

KEYNOTE:
Dr. Walter G. Copan, Under Secretary of Commerce for Standards and Technology and Director, NIST

4:20 PM: DAY ONE CLOSING REMARKS

KEYNOTE:
John Trainer, Vice President & Head, Partnering & Strategy, MedImmune

4:30 PM: GENERAL RECEPTION

8:00 AM: ARRIVAL

Registration, Breakfast, Networking

8:30 AM: CREATING COMPANIES FROM AN OPEN SCIENCE ECOSYSTEM

KEYNOTE:
Aled Edwards, PhD, Chief Executive, Structural Genomics Consortium (SGC), University of Toronto

9:00 AM: CRAB TRAP

MODERATOR:
Rich Bendis, President & CEO, BioHealth Innovation Inc.

JUDGES:
Shaun Grady, Vice President, Business Development Operations, AstraZeneca
Sara Nayeem, MD, Partner, New Enterprise Associates
John Rubin, JP Morgan
Paul Silber, PhD, Founding Principal, Blu Venture Investors
Robert Silverman, Head, Externalized Drug Discovery Partnering, Roche
Steven Zachary, Associate, Sands Capital Ventures

10:10 AM: BHCR Spotlight

SPEAKER:
James C. Powers, Chairman & CEO, HemoShear Therapeutics
Michael L. Salgaller, PhD, Supervisor, Invention Development and Marketing Unit, National Cancer Institute, National Institutes of Health

10:20 AM: NETWORKING BREAK

11:45 AM: LAUNCHING AN AUTOIMMUNE FOCUSED BIOTECH SPINOFF FROM MEDIMMUNE: VIELA BIO

INTRODUCTION:
Lily Qi, Assistant Chief Administrative Officer, Montgomery County Office of the County Executive

KEYNOTE:
Dr. Bing Yao, CEO, Viela Bio

12:05 PM: LUNCH

1:05 PM: PUBLIC SUPPORT FOR BIOHEALTH ENTREPRENEURS

MODERATOR:
Beth Meagher, Deloitte Consulting Principal, Deloitte

PANELISTS:
Rich Bendis, President & CEO, BioHealth Innovation Inc.
Jeffrey M. Gallagher, CEO, Virginia Bio
Tami Howie, CEO, Maryland Tech Council
Jason Miller, CEO, Greater Washington Partnership
Bret Schreiber, Senior Director, Office of BioHealth and Life Sciences, Maryland Department of Commerce

2:00 PM: KEYNOTE FROM SECRETARY OF HEALTH & HUMAN SERVICES, ALEX M. AZAR II

KEYNOTE:

Alex M. Azar II, Secretary, U.S. Department of Health and Human Services

2:20 PM: USING PATIENT INPUT TO DRIVE AND IMPROVE BIOMEDICAL INNOVATION

MODERATOR:
Margaret Anderson, Managing Director, Deloitte Consulting LLP

PANELISTS:
Lisa M. Guay-Woodford, MD, Director, Center for Translational Science, Children’s National Health System
Vasum Peiris, MD, MPH, FAAP, FACC, FASE, Chief Medical Officer, Pediatrics and Special Population, U.S. Food & Drug Administration
Marshall Summar, MD, Director, Rare Disease Institute, Children’s National Medical Center

3:10 PM: ROLE OF HOSPITALS IN CATALYZING HEALTH INNOVATION

MODERATOR:
Tina Reed, Executive Healthcare & Hospitals Editor, FierceHealthcare

SPEAKERS:
Kurt Newman, MD, President & CEO, Children’s National Health System
Todd A. Stottlemyer, CEO, Inova Center for Personalized Health

4:00 PM: CLOSING REMARKS

KEYNOTE:
Rich Bendis, President & CEO, BioHealth Innovation Inc.